GlaxoSmithkline Consumer Healthcare has reported results for the fourth quarter and year ended March 31, 2016.
The company has posted a fall of 8.18% in its net profit at Rs 180.68 crore for the quarter ended March 31, 2016 as compared to Rs 196.78 crore for the same quarter in the previous year. Total income of the company has decreased by 8.52% at Rs 1166.4 crore for quarter under review as compared to Rs 1275.02 crore for the quarter ended March 31, 2015.
For the year ended March 31, 2016, the company has posted a rise of 17.70% in its net profit at Rs 686.91 crore as compared to Rs 583.6 crore for the same period in the previous year. Total income of company increased 1.28% at Rs 4587.47 crore for year under review as compared to Rs 4529.48 crore for the period ended March 31, 2015.
